Astec Lifesciences Ltd (ASTEC) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 574204, "name": "Astec Lifescienc", "stock_name": "Astec Lifescienc", "full_name": "Astec Lifesciences Ltd", "name_url": "stocks-analysis/astec-lifescienc", "exchange": 1, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "593.25", "chg": 7.45, "chgp": "1.27%", "dir": 1, "prev_price": "585.80", "mcapval": "1,328.00 Cr", "mcap": "Small Cap", "scripcode": 533138, "symbol": "ASTEC", "ind_name": "Pesticides & Agrochemicals", "ind_code": 18, "indexname": "", "isin": "INE563J01010", "curr_date": "Feb 03", "curr_time": "", "bse_nse_vol": "50.57 k", "exc_status": "Active", "traded_date": "Feb 03, 2026", "traded_date_str": "2026 02 03", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astec-lifescienc-574204-1&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "HT", "url": "https://www.marketsmojo.com/mojopro/strategy/1", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astec-lifescienc-574204-1&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Astec Lifesciences Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/astec-lifesciences-ltd-is-rated-strong-sell-3816278", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AstecLifescienc_mojoScore_3816278.png", "date": "2026-02-02 10:10:26", "description": "Astec Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 September 2024. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 02 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Astec Lifesciences Ltd Falls to 52-Week Low Amidst Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/astec-lifesciences-ltd-falls-to-52-week-low-amidst-continued-downtrend-3814622", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AstecLifescienc_priceRelatedfactors_3814622.png", "date": "2026-02-01 12:42:53", "description": "Astec Lifesciences Ltd, a player in the Pesticides & Agrochemicals sector, has touched a new 52-week low of Rs.555.4 today, marking a significant decline in its stock price amid a broader sectoral downturn and persistent underperformance over the past year." }, { "title": "Are Astec Lifesciences Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-astec-lifesciences-ltd-latest-results-good-or-bad-3813293", "imagepath": "", "date": "2026-01-31 19:18:53", "description": "Astec Lifesciences Ltd's latest financial results for the quarter ended December 2025 present a complex picture of operational performance. The company reported a net loss of ₹15.70 crores, which reflects a significant year-on-year deterioration of 61.12%. This marks the continuation of a challenging trend, as Astec has now recorded nine consecutive quarters of losses, raising concerns about the viability of its business model.\n\nOn a more positive note, the company achieved a revenue of ₹124.72 crores, indicating a year-on-year growth of 32.88%. This growth is noteworthy, particularly as it represents a substantial sequential improvement of 69.18% from the previous quarter, suggesting some recovery in demand for its agrochemical products. However, despite this revenue growth, the operating margin remains low at 3.20%, which, while an improvement from negative margins in prior quarters, still falls short of ..." }, { "title": "Astec Lifesciences Gains 0.54%: 2 Key Factors Shaping This Week’s Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/astec-lifesciences-gains-054-2-key-factors-shaping-this-weeks-performance-3813109", "imagepath": "", "date": "2026-01-31 17:01:20", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Jan 27:</strong> New 52-week low (Rs.559.3)</p>\n <p><strong>Jan 30:</strong> Q3 FY26 results show deep losses despite revenue recovery</p>\n <p><strong>Week Close:</strong> Rs.574.40 (+0.54%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\">\n <div class=\"stat-label\">Week Open</div>\n <div class=\"stat-value\">Rs.571.30</div>\n </div>\n <div class=\"stat-item\">\n <div class=\"stat-label\">Week Close</div>\n <div class=\"stat-value\">Rs.574.40</div>\n ..." }, { "title": "Astec LifeSciences Q3 FY26: Deep Losses Persist Despite Revenue Recovery", "link": "https://www.marketsmojo.com/news/result-analysis/astec-lifesciences-q3-fy26-deep-losses-persist-despite-revenue-recovery-3811997", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AstecLifescienc_quaterlyResult_3811997.png", "date": "2026-01-30 20:01:37", "description": "Astec LifeSciences Ltd., a prominent manufacturer of agrochemical active ingredients and pharmaceutical intermediates, reported a consolidated net loss of ₹15.70 crores for Q3 FY26, representing a 61.12% deterioration compared to the ₹40.38-crore loss recorded in Q3 FY25. Despite a robust 32.88% year-on-year revenue expansion to ₹124.72 crores, the company continues to grapple with operational inefficiencies and mounting interest burdens that have kept profitability elusive. The stock, currently trading at ₹573.00 with a market capitalisation of ₹1,289 crores, has plunged 42.46% over the past year, significantly underperforming both the Sensex and its sectoral peers." }, { "title": "Astec Lifesciences Ltd Falls to 52-Week Low of Rs.559.3 Amidst Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/astec-lifesciences-ltd-falls-to-52-week-low-of-rs5593-amidst-continued-downtrend-3805642", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AstecLifescienc_priceRelatedfactors_3805642.png", "date": "2026-01-27 10:12:08", "description": "Astec Lifesciences Ltd, a player in the Pesticides & Agrochemicals sector, has touched a new 52-week low of Rs.559.3 today, marking a significant decline in its stock price amid persistent downward momentum and underperformance relative to its sector and benchmark indices." }, { "title": "Astec Lifesciences Declines 12.28%: Five Key Factors Behind the Steep Weekly Drop", "link": "https://www.marketsmojo.com/news/stocks-in-action/astec-lifesciences-declines-1228-five-key-factors-behind-the-steep-weekly-drop-3803619", "imagepath": "", "date": "2026-01-24 17:00:08", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Jan 19:</strong> Stock opens strong at Rs.660.85 (+1.47%) despite Sensex decline</p>\n <p><strong>Jan 20:</strong> Intraday low hit at Rs.611.30 amid heavy price pressure</p>\n <p><strong>Jan 21:</strong> New 52-week low of Rs.603 recorded as downtrend intensifies</p>\n <p><strong>Jan 22:</strong> Slight recovery to Rs.595.10 (+1.41%) on moderate volume</p>\n <p><strong>Jan 23:</strong> Week closes at Rs.571.30, another 52-week low and -4.00% drop</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"sta..." }, { "title": "Astec Lifesciences Ltd Falls to 52-Week Low Amidst Continued Underperformance", "link": "https://www.marketsmojo.com/news/stocks-in-action/astec-lifesciences-ltd-falls-to-52-week-low-amidst-continued-underperformance-3801900", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AstecLifescienc_priceRelatedfactors_3801900.png", "date": "2026-01-23 13:38:02", "description": "Astec Lifesciences Ltd, a key player in the Pesticides & Agrochemicals sector, recorded a new 52-week low of Rs.575.45 today, marking a significant decline in its stock price amid broader market pressures and company-specific financial strains." }, { "title": "Astec Lifesciences Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/astec-lifesciences-ltd-is-rated-strong-sell-3799917", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AstecLifescienc_mojoScore_3799917.png", "date": "2026-01-22 10:10:23", "description": "Astec Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 September 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 22 January 2026, providing investors with an up-to-date perspective on its performance and prospects." } ], "total": 217, "sid": "574204", "stock_news_url": "https://www.marketsmojo.com/news/astec-lifesciences-574204" }, "announcements": [ { "details": "Astec LifeSciences Limited has informed the Exchange that Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has submitted a copy of disclosure on Related Party Transactions for the Half Year ended September 30, 2019 on a consolidated basis, drawn in accordance with the applicable Accounting Standards.", "source": "NSE", "caption": "Astec LifeSciences Limited - Other General Purpose", "datetime": "22-Nov-2019" }, { "details": " <table><tr><td>Astec LifeSciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 26, 2019. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. </td></tr></table>", "source": "NSE", "caption": "Shareholders meeting", "datetime": "27-Jul-2019" }, { "details": " <table><tr><td>Astec LifeSciences Limited has informed the Exchange regarding Outcome of Board Meeting held on July 26, 2019. </td></tr></table>", "source": "NSE", "caption": "Outcome of Board Meeting", "datetime": "26-Jul-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Astec Lifesciences Ltd has declared <strong>15%</strong> dividend, ex-date: 21 Jul 23", "dt": "2023-07-21", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Astec Lifesciences Ltd has announced <strong>1:7</strong> rights issue, ex-date: 04 Jul 25", "dt": "2025-07-04", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

Jan 19: Stock opens strong at Rs.660.85 (+1.47%) despite Sensex decline

Jan 20: Intraday low hit at Rs.611.30 amid heavy price pressure

Jan 21: New 52-week low of Rs.603 recorded as downtrend intensifies

Jan 22: Slight recovery to Rs.595.10 (+1.41%) on moderate volume

Jan 23: Week closes at Rs.571.30, another 52-week low and -4.00% drop

Week Open

Read full news article

Astec Lifesciences Ltd Falls to 52-Week Low Amidst Continued Underperformance

2026-01-23 13:38:02

Astec Lifesciences Ltd, a key player in the Pesticides & Agrochemicals sector, recorded a new 52-week low of Rs.575.45 today, marking a significant decline in its stock price amid broader market pressures and company-specific financial strains.

Read full news article

Astec Lifesciences Ltd is Rated Strong Sell

2026-01-22 10:10:23

Astec Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 September 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 22 January 2026, providing investors with an up-to-date perspective on its performance and prospects.

Read full news article